---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-23-000049"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2023-07-31T23:59:59+00:00"
generated_at: "2026-06-12T21:39:00.166334+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PetMed Express Q1 net sales $78.2M (+11.5% YoY); net loss $(0.9)M; declares $0.30 dividend

## Summary
- Net sales $78.2M, up 11.5% YoY from $70.2M; net loss $(0.9)M ($0.04 diluted loss) vs net income $2.8M ($0.14 EPS) in prior year.
- Adjusted EBITDA $3.3M, down 47% from $6.3M; new customers up 25% YoY (third consecutive quarter).
- Board declared quarterly dividend $0.30/share, payable Aug 18, 2023 to holders of record Aug 14, 2023.
- Acquisition of PetCareRx closed Apr 3, 2023; contributed almost full quarter of consolidated results.

## SEC filing metadata
- accession: 0001040130-23-000049
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2023-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/0001040130-23-000049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/pets-20230731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-23-000049
- JSON: https://secwatch.observer/filing/0001040130-23-000049.json
- Plain text: https://secwatch.observer/filing/0001040130-23-000049.txt

## Key facts
- Earnings Releases
  PETMED EXPRESS INC reported first quarter ended June 30, 2023 results: revenue $78.2 million, net income Net loss for the quarter ended June 30, 2023 was $(0.9) million, EPS $(0.04) per diluted share.
  - Period: first quarter ended June 30, 2023
  - Revenue: $78.2 million
  - Net income: Net loss for the quarter ended June 30, 2023 was $(0.9) million
  - EPS: $(0.04) per diluted share
  - Result: reported results
  source text: Health Expert TM , today announced its financial results for its first quarter ended June 30, 2023. Quarterly Highlights • Net sales for the quarter ended June 30, 2023, were $78.2 million, compared to $70.2 million for the first quarter in the prior year, an increase of 11.5%. • PetMeds reported an increase in new customers of 25% year over year for the quarter
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013023000049/0001040130-23-000049-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.